Exploring lincRNA's role in breast cancer

Fox Chase researchers identify abnormally expressed lincRNAs in breast cancer patients, establishing a new path for understanding how cancer works

2013-04-09

(Press-News.org) WASHINGTON, DC (April 8, 2013)—Once considered part of the "junk" of our genome, much of the DNA between protein-coding genes is now known to be transcribed. New findings by scientists at Fox Chase Cancer Center have identified several dozen transcripts known as lincRNAs, or long intergenic non-coding RNAs, that are dysregulated in breast cancer. The results, to be presented at the AACR Annual Meeting 2013 on Monday, April 8, offer both a new research path for better understanding of how breast cancer works and a new method for identifying lincRNAs that may contribute to tumorigenesis or regulation of other cancers. "This is a very preliminary result," says study author Xiaowei Chen, PhD, assistant professor at Fox Chase, "because we spent most of our time trying to define how to pull out the useful information" from the region of the genome between protein-coding genes. Even though "the overall concept is new," says Chen, in the end the team settled on standard methods for each step of the genome-wide approach for identifying lincRNA-coding regions. In the study, researchers conducted pairwise comparisons of genomic information between five tumor samples and the adjacent normal cells. That comparison yielded 47 lincRNA transcripts, of which the team selected the most prevalent 14. They then checked how these lincRNAs were expressed by 12 established breast cancer cell lines and four non-cancerous cell lines. The team found that expression varied widely, indicating that lincRNAs are differentially regulated within breast cancer cell lines. "We wanted to identify the changes in order to find some candidates," says Chen, rather than identify all candidates; "there are many more, I believe." The next step will be to conduct a functional analysis of these 14 most prevalent transcripts to see if the expression has any biological meaning. Already, the team has identified one lincRNA gene that Chen says "looks pretty promising," but full results will come later. ### Co-authors on the study include Zhengyu Jiang, Yan Zhou, Karthik Devarajan, Carolyn M. Slater, and Mary B. Daly of Fox Chase. Fox Chase Cancer Center, part of Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase also was among the first institutions to receive the National Cancer Institute's prestigious comprehensive cancer center designation in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are routinely recognized in national rankings, and the Center's nursing program has achieved Magnet status for excellence three consecutive times. Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research and oversees programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX-CHASE (1-888-369-2427) or visit http://www.foxchase.org. END

ELSE PRESS RELEASES FROM THIS DATE:

Minocycline, an antibiotic, improves behavior for children with fragile X syndrome

2013-04-09

Minocycline, an older, broad-spectrum antibiotic in the tetracycline family, provides meaningful improvements as a therapeutic for children with fragile X syndrome, a study by researchers at the UC Davis MIND Institute has found. The finding is important, the researchers said, because minocycline is a targeted treatment for the condition that is readily available by prescription. After three months of treatment with minocycline, children with fragile X syndrome had greater improvements in general behavior, anxiety and mood-related behaviors when compared with children ...

Certain breast cancer patients may benefit from combined HER2 targeted therapy without chemotherapy

2013-04-09

HOUSTON – (April 8, 2013) – Is the era of targeted therapy for breast cancer at hand? It could be, said experts at the Lester and Sue Smith Breast Center at Baylor College of Medicine – at least for a certain population of women. In a report that appears online today in the Journal of Clinical Oncology, the researchers have shown that a subset of breast cancer patients who have tumors overexpressing a protein called the human epidermal growth factor receptor 2 (HER-2 positive) may benefit from a combination of targeted treatments that zero in on the breast cancer cells ...

Surprising predictor of ecosystem chemistry

2013-04-09

Washington, D.C.— Carnegie scientists have found that the plant species making up an ecosystem are better predictors of ecosystem chemistry than environmental conditions such as terrain, geology, or altitude. This is the first study using a new, high-resolution airborne, chemical-detecting instrument to map multiple ecosystem chemicals. The result, published in the April 8, 2013, Early Edition of the Proceedings of the National Academy of Sciences, is a key step toward understanding how species composition affects carbon, nitrogen and other nutrient cycling, and the effects ...

Heart surgery increases death risk for cancer survivors who had radiation

2013-04-09

Cancer survivors who had chest radiation are nearly twice as likely to die in the years after having major heart surgery as similar patients who didn't have radiation, according to research in the American Heart Association journal Circulation. Chest radiation to kill or shrink breast cancer, Hodgkin's lymphoma and other cancers increases survivors' risk for major heart disease years — even decades — after radiation therapy. "While radiation treatments done on children and adults in the late 1960s, '70s and '80s played an important role in cancer survival, the treatment ...

'Spooky action at a distance' aboard the ISS

2013-04-09

Albert Einstein famously described quantum entanglement as "spooky action at distance"; however, up until now experiments that examine this peculiar aspect of physics have been limited to relatively small distances on Earth. In a new study published today, 9 April, in the Institute of Physics and German Physical Society's New Journal of Physics, researchers have proposed using the International Space Station (ISS) to test the limits of this "spooky action" and potentially help to develop the first global quantum communication network. Their plans include a so-called ...

Antibiotic brings some improvement in fragile X syndrome, reports JDBP

2013-04-09

Philadelphia, Pa. (April 8, 2012) – The antibiotic drug minocycline yields "modest" but meaningful improvements in functioning and mood for children with fragile X syndrome (FXS), reports a study in the April Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. Three months of treatment with minocycline in children with FXS resulted in greater overall improvement than placebo treatment, according to ...

No map, no problems for monarchs

2013-04-09

Monarch butterflies have long been admired for their sense of direction, as they migrate from Canada and the United States to Mexico. According to new findings from a team of scientists, including researchers from the University of Guelph, the winged insects fly without a map, and use basic orientation and landmarks to find their way to their wintering sites, thousands of miles away. Recently published in the Proceedings of the National Academy of Sciences USA, the study examined the insects' flight patterns and whether those patterns changed when the butterflies were ...

Debunking a myth: IUDs proven safe birth control for teenagers

2013-04-09

Intrauterine devices (IUDs) are as safe for teenagers – including those who have never given birth – as they are for adults, according to research from the University of Texas Medical Branch at Galveston. Published in the May issue of Obstetrics & Gynecology, the findings disprove concerns that have persisted for more than 30 years, since the removal of a harmful IUD from the market in the 1970's, and open the door for many more women – teens included – to benefit from the highly effective, long-lasting form of contraception. "Today's IUDs are not the same as the ones ...

Alcohol consumption has no impact on breast cancer survival

2013-04-09

SEATTLE – Although previous research has linked alcohol consumption to an increased risk of developing breast cancer, a new study has found that drinking before and after diagnosis does not impact survival from the disease. In fact, a modest survival benefit was found in women who were moderate drinkers before and after diagnosis due to a reduced risk of dying from cardiovascular disease, a major cause of mortality among breast cancer survivors. The study results will be published in the April 8 edition of the Journal of Clinical Oncology. Polly Newcomb, Ph.D., a member ...

Canada loses out on drug pricing: UBC study

2013-04-09

Health systems worldwide are increasingly negotiating secret price rebates from pharmaceutical companies and Canadians risk losing out on the deal. "The pricing of medicines is now a game of negotiation, similar to buying a car at a dealership," says Steve Morgan, an expert in health policy at the University of British Columbia. "There's a list price equivalent to a manufacturer's suggested retail price; and then there's secret deals that everyone negotiates from there." In a study published today in the April issue of the journal Health Affairs, researchers interviewed ...